F. Tas Et Al. , "Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma," TUMOR BIOLOGY , vol.35, no.7, pp.7233-7237, 2014
Tas, F. Et Al. 2014. Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma. TUMOR BIOLOGY , vol.35, no.7 , 7233-7237.
Tas, F., Karabulut, S., Yasasever, C., & Duranyildiz, D., (2014). Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma. TUMOR BIOLOGY , vol.35, no.7, 7233-7237.
Tas, Faruk Et Al. "Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma," TUMOR BIOLOGY , vol.35, no.7, 7233-7237, 2014
Tas, Faruk Et Al. "Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma." TUMOR BIOLOGY , vol.35, no.7, pp.7233-7237, 2014
Tas, F. Et Al. (2014) . "Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma." TUMOR BIOLOGY , vol.35, no.7, pp.7233-7237.
@article{article, author={Faruk TAŞ Et Al. }, title={Serum transforming growth factor-beta 1 (TGF-beta 1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma}, journal={TUMOR BIOLOGY}, year=2014, pages={7233-7237} }